CagA status and Helicobacter pylori eradication among dyspeptic patients
- PMID: 16185577
- DOI: 10.1157/13078993
CagA status and Helicobacter pylori eradication among dyspeptic patients
Abstract
Aim: Triple therapy seems more effective in curing Helicobacter pylori infection in patients with peptic ulcer than in those with non-ulcer dyspepsia. It has been suggested that this difference depends on the expression of CagA protein that is more frequent in the former. The objective of this study was to investigate a potential association between serum CagA positivity, severity of gastric mucosal inflammation and eradication success among peptic ulcer and non-ulcer dyspepsia patients.
Material and method: Patients undergoing upper gastrointestinal endoscopy for investigation of dyspepsia at the Department of Gastroenterology, Hospital Vera Cruz, between March, 2000 and March 2001 were screened. H. pylori positive patients, as diagnosed by rapid urease test and histology were included. Severity of gastric mucosal inflammation was determined and serum CagA positivity was assessed using a commercially available ELISA assay prior to H. pylori 7-day eradication therapy with lansoprazole, clarithromycin and amoxicillin (30 mg, 500 mg and 1 g b.i.d., respectively). Eradication success was determined 8-24 weeks following completion of therapy.
Results: Seventy-four patients were included in the study (mean age 40.8, range 18-67, female = 28). CagA positivity was observed in 48% of patients. Gastroduodenal peptic ulceration was found in 54% of patients. Serum CagA positivity was significantly higher among peptic ulcer patients (62.5%), while CagA negativity was significantly higher among non-ulcer dyspepsia patients (67.7%). Lymphocyte and eosinophil infiltration was significantly higher among CagA + patients, despite being comparable when distributed among peptic ulcer and non-ulcer dyspepsia patients. Eradication was successful in 93.2% of patients, regardless of CagA status on a per protocol analysis. Based on a per protocol analysis, eradication success was comparable among peptic ulcer and non-ulcer dyspepsia patients, regardless of CagA status.
Conclusion: Our results support the concept that CagA positivity is associated to peptic ulcer disease and to a higher severity of lymphocyte and eosinophil infiltration. Efficacy of treatment eradication of H. pylori may not be affected by serum CagA status.
Similar articles
-
Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.Scand J Gastroenterol. 1998 Mar;33(3):231-5. doi: 10.1080/00365529850170775. Scand J Gastroenterol. 1998. PMID: 9548613 Clinical Trial.
-
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?Turk J Gastroenterol. 2005 Mar;16(1):29-33. Turk J Gastroenterol. 2005. PMID: 16252185
-
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.J Gastroenterol. 2003;38(4):339-47. doi: 10.1007/s005350300061. J Gastroenterol. 2003. PMID: 12743773 Clinical Trial.
-
[Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].Nihon Rinsho. 1999 Jan;57(1):127-33. Nihon Rinsho. 1999. PMID: 10036949 Review. Japanese.
-
Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis.Helicobacter. 1998 Sep;3(3):195-201. doi: 10.1046/j.1523-5378.1998.08029.x. Helicobacter. 1998. PMID: 9731991
Cited by
-
Epstein-Barr virus association with peptic ulcer disease.Anal Cell Pathol (Amst). 2015;2015:164840. doi: 10.1155/2015/164840. Epub 2015 Jun 24. Anal Cell Pathol (Amst). 2015. PMID: 26199856 Free PMC article.
-
The association between vacA or cagA status and eradication outcome of Helicobacter pylori infection: A meta-analysis.PLoS One. 2017 May 11;12(5):e0177455. doi: 10.1371/journal.pone.0177455. eCollection 2017. PLoS One. 2017. PMID: 28493953 Free PMC article.
-
Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis.BMC Infect Dis. 2022 Jun 25;22(1):573. doi: 10.1186/s12879-022-07546-5. BMC Infect Dis. 2022. PMID: 35752757 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical